These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16601328

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

  • 24. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E, Okin PM, Boman K, Wachtell K, Nieminen MS, Dahlöf B, Devereux RB.
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG, Omotoso AB, Akande AA.
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators.
    Circulation; 2009 Apr 14; 119(14):1883-91. PubMed ID: 19332468
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Coronary artery calcification and ECG pattern of left ventricular hypertrophy or strain identify different healthy individuals at risk.
    Diederichsen SZ, Gerke O, Olsen MH, Lambrechtsen J, Sand NP, Nørgaard BL, Mickley H, Diederichsen AC.
    J Hypertens; 2013 Mar 14; 31(3):595-600; discussion 600. PubMed ID: 23462709
    [Abstract] [Full Text] [Related]

  • 39. Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Kontos J, Papademetriou V, Wachtell K, Palmieri V, Liu JE, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hum Hypertens; 2004 Jun 14; 18(6):431-6. PubMed ID: 15042117
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.